Bcl-2 Family Proteins and the Hormonal Control of Cell Life and Death in Normalcy and Neoplasia

Vitamins and Hormones

Volumn 53, Issue C, 1997, Pages 99-138

  Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE; PROTEIN BCL 2;

ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DIMERIZATION; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; HUMAN; NEOPLASM; PATHOLOGY; PHYSIOLOGY; REVIEW;

ANIMALS; CELL DEATH; CELL SURVIVAL; DIMERIZATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION; HORMONES; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0030632191     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60705-0     Document Type: Article

References (161)

1. Albrecht H., Tschopp J., and Jongeneel C.V. Bcl-2 protects from oxidative damage and apoptotic cell death without interfering with activation of NF-kB by TNF. FEBS Lett. 351 (1994) 45-48
2. Alnemri E.S., Fernandes T.F., Haldar S., Croce C.M., and Litwack G. Involvement of Bcl-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias. Cancer Res. 52 (1992) 491-495
3. Alnemri E.S., Robertson N.M., Fernandes T.F., Croce C.M., and Litwack G. Overexpressed full-length human bcl-2 extends the survival of baculovirus-infected Sf9 insect cells. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7295-7299
4. Baffy G., Miyashita T., Williamson J.R., and Reed J.C. Apoptosis is induced by withdrawal of interleukin-3 [IL-3] from an IL-3-dependent hematopoietic cell line associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J. Biol. Chem. 268 (1993) 6511-6519
5. Bargou R.C., Daniel P.T., Mapara M.Y., Bommert K., Wagenert K., Wagener C., Kallinich B., Royer H.D., and Dörken B. Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int. J. Cancer 60 (1995) 854-859
6. Bargou R.C., Wagener C., Bommert K., Mapara M.Y., Daniel P.T., Arnold W., Dietel M., Guski H., Feller A., Royer H.D., and Dörken B. Induction of the death promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Invest. (1995) in press
7. Benito A., Grillot D., Nunez G., and Fernandez-Luna J.L. Regulation and function of Bcl-2 during differentiation-induced cell death in HL-60 promyelocyte cells. Am. J. Pathol. 146 (1995) 481-490
8. Berchem G.J., Bosseler M., Sugars L.Y., Voeller H.J., Zeitlin S., and Gelmann E.P. Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res. 55 (1995) 735-738
9. Berges R.R., Furuya Y., Remington L., English H.F., Jacks T., and Isaacs J.T. Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 8910-8914
10. Binder C., Marx D., Overhoff R., Binder L., Schauer A., and Hiddemann W. Bcl-2 protein expression in breast cancer in relation to established prognostic factors and other clinicopathological variables. Ann. Oncol. 6 (1995) 1005-1010
11. Blagosklonny M.V., Schulte T.W., Nguyen P., Mimnaugh E.G., Trepel J., and Neckers L. Taxol induction of p21WAF1 and p53 requires c-raf-1. Cancer Res. 55 (1995) 4623-4626
12. Blagosklonny M.V., Schulte T., Nguyen P., Trepel J., and Neckers L.M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res. (1995) in press
13. Bodrug S.E., Aimé-Sempé C., Sato T., Krajewski S., Hanada M., and Reed J.C. Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Differ. 2 (1995) 173-182
14. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., and Thompson C.B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993) 597-608
15. Borner C., Martinou I., Mattmann C., Irmler M., Scharer E., Martinou J.-C., and Tschopp J. The protein bcl-2alpha does not require membrane attachment, but two conserved domains to suppress apoptosis. J. Cell Biol. 126 (1994) 1059-1068
16. Boulakia C.A., Chen G., Ng F.W.H., Teodoro J.G., Branton P.E., Nicholson D.W., Poirier G.G., and Shore G.C. Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 12 (1996) 29-36
17. Boyd J.M., Malstrom S., Subramanian T., Venkatesch L.K., Schaeper U., Elangovan B., D'Sa-Epper C., and Chinnadurai G. Adenovirus E1B 19 kDa and bcl-2 proteins interact with a common set of cellular proteins. Cell 79 (1993) 341-351
18. Boyd J.M., Gallo G.J., Elangovan B., Houghton A.B., Malstrom S., Avery B.J., Ebb R.G., Subramanian T., Chittenden T., Lutz R.J., and Chinnadurai G. Bik, a novel death-inducing protein, shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11 (1995) 1921-1928
19. Branet F., Brousset P., Krajewski S., Schlaifer D., Selves J., Reed J.C., and Caron P. Expression of the cell death-inducing gene Bax in carcinomas developed from the follicular cells of the thyroid gland. J. Clin. Endocrinol. Metab. 81 (1996) 2726-2730
20. Bubendorf L., Sauter G., Moch H., Jordan P., Gasser T.C., and Mihatsch M.J. Prognostic significance of bcl-2 in clinically localized prostate cancer. Am. J. Pathol. (1996) in press
21. Campos L., Roualult J.-P., Sabido O., Roubi N., Vasselon C., Archimbaud E., Magaud J.-P., and Guyotat D. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood 81 (1993) 3091-3096
22. Campos L., Sabido O., Rouault J.-P., and Guyotat D. Effects of Bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84 (1994) 595-600
23. Chao D.T., Linette G.P., Boise L.H., White L.S., Thompson C.B., and Korsmeyer S.J. Bcl-XL and Bcl-2 repress a common pathway of cell death. J. Exp. Med. 182 (1995) 821-828
24. Chen C.Y., and Faller D.V. Direction of p21ras-generated signals towards cell growth or apoptosis is determined by protein kinase C and Bcl-2. Oncogene 11 (1995) 1487-1498
25. Chen C.-Y., and Faller D.V. Phosphorylation of Bcl-2 protein and association with p21Ras in Ras-induced apoptosis. J. Biol. Chem. 271 (1996) 2376-2379
26. Cheng E.H.-Y., Levine B., Boise L.H., Thompson C.B., and Hardwick J.M. Bax-independent inhibition of apoptosis by Bcl-XL. Nature (London) 379 (1996) 554-556
27. Chinnaiyan A.M., Orth K., O'Rourke K., Duan H., Poirier G.G., and Dixit V.M. Molecular ordering of the cell death pathway: Bcl-2 and Bcl-XL function upstream of the CED-3-like apoptotic proteases. J. Biol. Chem. 271 (1996) 4573-4576
28. Chittenden T., Flemington C., Houghton A.B., Ebb R.G., Gallo G.J., Elangovan B., Chinnadurai G., and Lutz R.J. A conserved domain in Bak, distinct from BH1 and BH2, mediates cell death and protein binding functions. EMBO J. 14 (1995) 5589-5596
29. Chittenden T., Harrington E.A., O'Connor R., Flemington C., Lutz R.J., Evan G.I., and Guild B.C. Induction of apoptosis by the Bcl-2 homologue Bak. Nature (London) 374 (1995) 733-736
30. Choi S.S., Park I.-C., Yun J.W., Sung Y.C., Hong S., and Shin H. A novel Bcl-2 related gene, Bfl-1, is overexpressed in stomach cancer and preferentially expressed in bone marrow. Oncogene 11 (1995) 1693-1698
31. Colombel M., Symmans F., Gil S., O'Toole K.M., Chopin D., Benson M., Olsson C.A., Korsmeyer S., and Buttyan R. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am. J. Pathol. 143 (1993) 390-400
32. Daniel C.W., and Silberstein G.B. "The Mammary Gland: Development, Regulation and Function" (1987), Plenum Publishing Corp., New York
33. Das R., Reddy E.P., Chatterjee D., and Adrews D.W. Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma. Oncogene 12 (1996) 947-951
34. Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J.C., and Pierott M.A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2. Blood 85 (1995) 59-367
35. Doglioni C., Dei Tos A.P., Laurino L., Chiarelli C., Barbareschi M., and Viale G. The prevalence of Bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Archiv 424 (1994) 47-51
36. Dowd D.R., MacDonald P.N., Komm B.S., Haussler M.R., and Miesfeld R.L. Stable expression of the calbindin-D28K complementary DNA interferes with the apoptotic pathway in lymphocytes. Mol. Endocrinol. 6 (1992) 1843-1848
37. Eliopoulos A.G., Kerr D.J., Herod J., Hodgkins L., Krajewski S., Reed J.C., and Young L.S. The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2. Oncogene 11 (1995) 1217-1228
38. Farrow S.N., White J.H.M., Martinou I., Raven T., Pun K.-T., Grinham C.J., Martinou J.-C., and Brown R. Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19K. Nature (London) 374 (1995) 731-733
39. Fernandez-Sarbia M.J., and Bischoff J.R. Bcl-2 associates with the ras-related protein R-ras p23. Nature (London) 366 (1993) 274-275
40. Frisch S.M., and Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124 (1994) 619-626
41. Furuya Y., Krajewski S., Epstein J.I., Reed J.C., and Isaacs J.T. Enhanced expression of Bcl-2 and the progression of human and rodent prostatic cancers. Clin. Cancer Res. 2 (1996) 389-398
42. Gasparini G., Barbareschi M., Doglioni C., Palma P.D., Mauri F.A., Boracchi P., Bevilacqua P., Caffo O., Morelli L., Verderio P., Pezzella F., and Harris A.L. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer. Clin. Cancer Res. 1 (1995) 189-198
43. Gillet G., Guerin M., Trembleau A., and Brun G. A Bcl-2-related gene is activated in avian cells transformed by the Rous sarcoma virus. EMBO J. 14 (1995) 1372-1381
44. Golemis E.A., Gyuris J., and Brent R. Interaction trap-two-hybrid system to identify interacting proteins. "Current Protocols in Molecular Biology" (1994), John Wiley &Sons, Inc., New York pp. 13.14.1-13.14.17
45. Gompel A., Sabourin J.C., Martin A., Yaneva H., Audouin J., Decroix Y., and Poitout P. Bcl-2 expression in normal endometrium during the menstrual cycle. Am. J. Pathol. 144 (1994) 1195-1202
46. González-Garcia M., Pérez-Ballestero R., Ding L., Duan L., Boise L.H., Thompson C.B., and Núez G. Bcl-XL is the major bcl-XmRNA form expressed during murine development and its product localizes to mitochondria. Development 120 (1994) 3033-3042
47. Haldar S., Jena N., and Croce C.M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4507-4511
48. Haldar S., Chintapallli J., and Croce C.M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56 (1996) 1253-1255
49. Hanada M., Aimé-Sempé C., Sato T., and Reed J.C. Structure-function analysis of bcl-2 protein: Identification of conserved domains important for homodimerization with bcl-2 and heterodimerization with bax. J. Biol. Chem. 270 (1995) 11962-11968
50. Hellemans P., van Dam P.A., Weyler J., van Oosterom A.T., Buytaert P., and Van Marck E. Prognostic value of bcl-2 expression in invasive breast cancer. Br. J. Cancer 72 (1995) 354-360
51. Hengartner M.O., and Horvitz H.R. C. elegans cell survival geneced-9 encodes a functional homolog of the mammlian proto-oncogene bcl-2. Cell 76 (1994) 665-676
52. Hermine O., Haioun C., Lepage E., d'Agay M.-F., Briere J., Lavignac C., Fillet G., Salles G., Marolleau J.-P., Diebold J., Reyes F., and Gaulard P. Prognostic significance of Bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Blood 87 (1996) 265-272
53. Herod J.J.O., Eliopoulos A.G., Warwick J., Niedobitek G., Young L.S., and Kerr D.J. The prognostic significance of Bcl-2 and p53 expression in ovarian carcinoma. Cancer Res. 56 (1996) 2178-2184
54. Hockenbery D.M., Nunez G., Milliman C., Schreiber R.D., and Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature (London) 348 (1990) 334-336
55. Hockenbery D.M., Zutter M., Hickey W., Nahm M., and Korsmeyer S.J. Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 6961-6965
56. Hockenbery D., Oltvai Z., Yin X.-M., Milliman C., and Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75 (1993) 241-251
57. Hunter J.J., and Parslow T.G. A peptide sequence from Bax that converts Bcl-2 into an activator of apoptosis. J. Biol. Chem. 271 (1996) 8521-8524
58. Hunter J.J., Bond B.L., and Parslow T.G. Functional dissection of the human Bcl-2 protein: Sequence requirements for inhibition of apoptosis. Mol. Cell. Biol. 16 (1996) 877-883
59. Jacobson M.D., and Raff M.C. Programmed cell death and Bcl-2 protection in very low oxygen. Nature (London) 374 (1995) 814-816
60. Jacobson M.D., Burne J.F., King M.P., Miyashita T., Reed J.C., and Raff M.C. Apoptosis and bcl-2 protein in cells without mitochondrial DNA. Nature (London) 361 (1993) 365-368
61. Joensuu H., Pylkkänen L., and Toikkanen S. Bcl-2 protein expression and long-term survival in breast cancer. Am. J. Pathol. 145 (1994) 1191-1198
62. Johnston S.R.D., MacLennan K.A., Sacks N.P.M., Salter J., Smith I.E., and Dowsett M. Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. Eur. J. Cancer 30A (1994) 1663-1669
63. Kamada S., Shimono A., Shinto Y., Tsujimura T., Takahashi T., Noda T., Kitamura Y., Kondoh H., and Tsujimoto Y. Bcl-2 deficiency in mice leads to pleiotropic abnormalities: Accelerated lymphoid cell death in thymus and spleen, polycystic kidney, hair hypopigmentation, and distorted small intestine. Cancer Res. 55 (1995) 354-359
64. Kane D.J., Sarafin T.A., Auton S., Hahn H., Gralla F.B., Valentine J.C., Ord T., and Bredesen D.E. Bcl-2 inhibition of neural cell death: Decreased generation of reactive oxygen species. Science 262 (1993) 1274-1276
65. Katsumata M., Siegel R., Louie D., Miyashita T., Tanaka S., Greene M., and Reed J.C. Differential effects of bcl-2 on B- and T-lymphocytes in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 11376-11380
66. Kiefer M.C., Brauer M.J., Powers V.C., Wu J.J., Ubansky S.R., Tomei L.D., and Barr P.J. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (London) 374 (1995) 736-739
67. Kitada S., Takayama S., DeRiel K., Tanaka S., and Reed J.C. Reversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expression. Antisense Res. Dev. 4 (1994) 71-79
68. Kitada S., Krajewski S., Miyashita T., Krajewska M., and Reed J.C. Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene 12 (1996) 187-192
69. Knudson C.M., Tung K.S.K., Tourtellotte W.G., Brown G.A.J., and Korsmeyer S.J. Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270 (1995) 96-99
70. Kozopas K.M., Yang T., Buchan H.L., Zhou P., and Craig R. Mcl-1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to bcl-2. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 3516-3520
71. Krajewska M., Krajewski S., Epstein J.I., Shabaik A., Sauvageot J., Song K., Kitada S., and Reed J.C. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in prostate cancers. Am. J. Pathol. 148 (1996) 1567-1576
72. Krajewska M., Moss S., Krajewski S., Song K., Holt P., and Reed J.C. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas. Cancer Res. 56 (1996) 2422-2427
73. Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., and Reed J.C. Investigations of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53 (1993) 4701-4714
74. Krajewski S., Krajewska M., Shabaik A., Miyashita T., Wang H.-G., and Reed J.C. Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am. J. Pathol. 145 (1994) 1323-1333
75. Krajewski S., Krajewska M., Shabaik A., Wang H.-G., Irie S., Fong L., and Reed J.C. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res. 54 (1994) 5501-5507
76. Krajewski S., Blomvqvist C., Franssila K., Krajewska M., Wasenius V.-M., Niskanen E., and Reed J.C. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res. 55 (1995) 4471-4478
77. Krajewski S., Bodrug S., Krajewska M., Shabaik A., Gascoyne R., Berean K., and Reed J.C. Immunohistochemical analysis of Mcl-1 protein in human tissues: Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am. J. Pathol. 146 (1995) 1309-1319
78. Krajewski S., Krajewska M., and Reed J.C. Immunohistochemical analysis of in vivo patterns of Bak expression, a pro-apoptotic member of the Bcl-2 protein family. Cancer Res. 56 (1996) 2849-2855
79. Kurschner C., and Morgan J.I. The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Mol. Brain Res. 30 (1995) 165-168
80. Kyprianou N., and Isaacs J.T. Activation of programmed cell death in the rat ventral prostate after eastration. Endocrinology 122 (1988) 552-562
81. Lam M., Dubyak G., and Distelhorst C.W. Effect of glucocorticosteroid treatment on intracellular calcium homeostasis in mouse lymphoma cells. Mol. Endocrinol. 7 (1993) 686-693
82. Lam M., Dubyak G., Chen L., Nuez G., Miesfeld R.L., and Distelhorst C.W. Evidence that Bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2 fluxes. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 6569-6573
83. Leek R.D., Kaklamanis L., Pezzella F., Gatter K.C., and Harris A.L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ. Cancer. Br. J. Cancer 69 (1994) 135-139
84. Li M., Hu J., Heermeier K., Henninghausen L., and Furth P.A. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways. Cell Growth Differ. 7 (1996) 13-20
85. Li M., Hu J., Heermeier K., Henninghausen L., and Furth P.A. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: Induction of p53-independent apoptosis is followed by impaired milk production in surviving cells. Cell Growth Differ. 7 (1996) 3-11
86. Lin E.Y., Orlofsky A., Berger M.S., and Prystowsky M.B. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J. Immunol. 151 (1993) 1979-1988
87. Lin E.Y., Orlofsky S., Wang H.-G., Reed J.C., and Prystowsky M.B. A1, a Bcl-2 family member, prolongs cell survival and permits myeloid differentiation. Blood 87 (1996) 983-992
88. Lin K.-I., Lee S.-H., Narayanan R., Baraban J.M., Hardwick J.M., and Ratan R.R. Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J. Cell Biol. 131 (1995) 1149-1161
89. Lithgow T., van Driel R., Bertram J.F., and Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the other mitochondrial membrane. Cell Growth Differ. 3 (1994) 411-417
90. Maung Z.T., MacLean F.R., Reid M.M., Pearson A.D.J., Proctor S.J., Hamilton P.J., and Hall A.G. The relationship between bcl-2 expression and response to chemotherapy in acute leukemia. Br. J. Haematol. 88 (1994) 105-109
91. McDonnell T.J., Deane N., Platt F.M., Nunez G., Jaeger V., McKearn J.P., and Korsmeyer S.J. Bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 57 (1989) 79-88
92. McDonnell T.J., Nunez G., Platt F.M., Hockenberry D., London L., McKearn J.P., and Korsmeyer S.J. Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol. Cell. Biol. 10 (1990) 1901-1907
93. McDonnell T.J., Troncoso P., Brisbay S.M., Logothetis C., Chung L.W.K., Hsieh J.-T., Tu S.-M., and Campbell M.L. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52 (1992) 6940-6944
94. Meikrantz W., Gisselbrecht S., Tam S.W., and Schlegel R. Activation of cyclin A-dependent protein kinases during apoptosis. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 3754-3758
95. Minn A.J., Rudin C.M., Boise L.H., and Thompson C.B. Expression of BclXL can confer a multidrug resistance phenotype. Blood 86 (1995) 1903-1910
96. Minn A.J., Boise L.H., and Thompson C.B. Bcl-XS antagonizes the protective effects of Bcl-XL. J. Biol. Chem. 271 (1996) 6306-6312
97. Miyashita T., and Reed J.C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res. 52 (1992) 5407-5411
98. Miyashita T., and Reed J.C. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81 (1993) 151-157
99. Miyashita T., and Reed J.C. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell 80 (1995) 293-299
100. Miyashita T., Harigai M., Hanada M., and Reed J.C. Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res. 54 (1994) 3131-3135
101. Miyashita T., Krajewski S., Krajewska M., Wang H.G., Lin H.K., Hoffman B., Lieberman D., and Reed J.C. Tumor suppressor p53 is a regulator of bcl-2 and bax in gene expression in vitro and in vivo. Oncogene 9 (1994) 1799-1805
102. Monaghan P., Robertson D., Andrew T., Amos S., Dyer M.J.S., Mason D.Y., and Greaves M.F. Ultrastructural localization of bcl-2 protein. J. Histochem. Cytochem. 40 (1992) 1819-1825
103. Motoyama N., Wang F., Roth K.A., Sawa H., Nakayama K., Negishi I., Senju S., Zhang Q., Fujii S., and Loh D.Y. Massive cell death of immature hematopoietic cells and neurons in Bcl-X-deficient mice. Science 267 (1995) 1506-1510
104. Nathan B., Anbazhagan R., Dyer M., Ebbs S.R., Jayatilake H., and Gusterson B.A. Expression of bcl-2-like immunoreactivity in the normal breast and in breast cancer. Breast 2 (1993) 134-137
105. Nathan B., Gusterson B., Jadayel D., O'Hare M., Anbazhagan R., Jayatilake H., Ebbs S., Micklem K., Price K., and Gelber R. Expression of BCL-2 in primary breast cancer and its correlation with tumour phenotype. Ann. Oncol. 5 (1994) 409-414 for the International (Ludwig) Breast Cancer Study Group
106. Naumovski L., and Cleary M.L. Bcl-2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83 (1994) 2261-2267
107. Naumovski L., and Cleary M.L. The p53-binding protein 53BP2 also interacts with Bcl-2 and impedes cell cycle progression at G2M. Mol. Cell Biol. 16 (1996) 3884-3892
108. Neilan J.G., Lu Z., Afonso C.L., Kutish G.F., Sussman M.D., and Rock D.L. An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. J. Virol. 67 (1993) 4391-4394
109. Offit K., Koduru P.R.K., Hollis R., Filippa D., Jhanwar S.C., Clarkson B.C., and Chaganti R.S.K. Q21 rearrangement in diffuse large cell lymphoma: Incidence and clinical significance. Br. J. Haematol. 72 (1989) 178-183
110. Oltvai Z., Milliman C., and Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74 (1993) 609-619
111. Perego P., Giarola M., Righetti S.C., Supino R., Caserini C., Delia D., Pierotti M.A., Miyashita T., Reed J.C., and Zunino F. Association between cisplatin resistance and mutation of p53 gene and reduced Bax expression in ovarian carcinoma cell systems. Cancer Res. 56 (1996) 556-562
112. Pezzella F., Tse A.G.D., Cordell J.L., Pulford K.A.F., Gatter K.C., and Mason D.Y. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am. J. Pathol. 137 (1990) 225
113. Pilotti S., Collini P., Rilke F., Cattoretti G., Del Bo R., and Pierotti M.A. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J. Pathol. 172 (1994) 337-342
114. Piris M.A., Pezella F., Martinez-Montero J.C., Orradre J.L., Villuendas R., Sanchez-Beato M., Cuena R., Cruz M.A., Martinez B., Garrido M.C., Gatter K., Aiello A., Delia D., Giardini R., and Rilke F. P53 and bcl-2 expression in high-grade B-cell lymphomas: Correlation with survival time. Br. J. Cancer 69 (1994) 337-341
115. Raffo A.J., Perlman H., Chen M.-W., Day M.L., Streitman J.S., and Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res. 55 (1995) 4438-4445
116. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., and White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and bcl-2 proteins. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7742-7746
117. Razin S.V., and Gromova I.I. The channels model of nuclear matrix structure. BioEssays 17 (1995) 443-450
118. Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 124 (1994) 1-6
119. Reed J.C. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol. Oncol. Clin. North Am. 9 (1995) 451-474
120. Reed J., Haldar S., Cuddy M., Croce C., and Makover D. Bcl-2-mediated tumorigenicity in a T-lymphoid cell line: Synergy with C-MYC and inhibition by Bcl-2 antisense. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 3660-3664
121. Reynolds J.E., Yang T., Qian L., Jenkinson J.D., Zhou P., Eastman A., and Craig R.W. Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 54 (1994) 6348-6352
122. Ruoslahti E., and Reed J.C. Anchorage dependence, integrins, and apoptosis. Cell 77 (1994) 477-478
123. Ryan J.J., Prochownik E., Gottlieb C.A., Apel I.J., Merino R., Nuez G., and Clarke M.F. C-myc and bcl-2 modulates p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 5878-5882
124. Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.-G., and Reed J.C. Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 9238-9242
125. Sato T., Irie S., Krajewski S., and Reed J.C. Cloning and sequencing of cDNA encoding rat bcl-2 protein. Gene 140 (1994) 291-292
126. Sato T., Hanada M., Bodrug S., Irie S., Iwama N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.-G., and Reed J.C. Correction: Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 1793
127. Sedlak T.W., Oltvai Z.N., Yang E., Wang K., Boise L.H., Thompson C.B., and Korsmeyer S.J. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7834-7838
128. Selvakumaran M., Lin H.-K., Miyashita T., Wang H.-G., Krajewski S., Reed J.C., Hoffman B., and Liebermann D. Immediate early up-regulation of bax expression by p53 but not TGFb1: A paradigm for distinct apoptotic pathways. Oncogene 9 (1994) 1791-1798
129. Sentman C.L., Shutter J.R., Hockenbery D., Kanagawa O., and Korsmeyer S.J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67 (1991) 879-888
130. Shabaik A.S., Krajewski S., Burgan A., Krajewska M., and Reed J.C. Bcl-2 proto-oncogene expression in normal, hyperplastic, and neoplastic prostate tissue. J. Urol. Pathol. 3 (1994) 17-27
131. Shen Y., and Shenk T. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular bcl-2 protein. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8940-8944
132. Shimizu S., Eguchi Y., Kosaka H., Kamiike W., Matsuda H., and Tsujimoto Y. Prevention of hypoxia-induced cell death by Bcl-2 and BclxL. Nature (London) 374 (1995) 811-813
133. Siegel R., Katsumata M., Miyashita T., Louie D., Greene M., and Reed J.C. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 7003-7007
134. Silvestrini R., Veneroni S., Daidone M.G., Benini E., Boracchi P., Mezzetti M., Di Fronzo G., Rilke F., and Veronesi U. The bcl-2 protein: A prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst. 86 (1994) 499-504
135. Smith C.A. A novel viral homologue of Bcl-2 and Ced-9. Trends Cell Biol. 5 (1995) 344
136. Strasser A., Harris A.W., and Cory S. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 67 (1991) 889-899
137. Sumantran V.N., Ealovega M.W., Nuez G., Clarke M.F., and Wicha M.S. Overexpression of Bcl-Xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res. 55 (1995) 2507-2510
138. Tabibzadeh S., Zupi E., Babaknia A., Liu R., Marconi D., and Romanini C. Site and menstrual cycle-dependent expression of proteins of the tumour necrosis factor (TNF) receptor family, and Bcl-2 oncoprotein and phase-specific production of TNFa in human endometrium. Hum. Reprod. 10 (1995) 277-286
139. Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J.A., and Reed J.C. Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80 (1995) 279-284
140. Teixeira C., Reed J.C., and Pratt M.A.C. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells. Cancer Res. 55 (1995) 3902-3907
141. Tilly J.L. Ovarian follicular atresia: A model to study the mechanisms of physiological cell death. Endocrine J. 1 (1993) 67-72
142. Tilly J.L., Tilly K.I., Kenton M.L., and Johnson A.L. Expression of members of the Bcl-2 gene family in the immature rat ovary: Equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-Xlong messenger ribonucleic acid levels. Endocrinology 136 (1995) 232-241
143. Tsujimoto Y., Cossman J., Jaffe E., and Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228 (1985) 1440-1443
144. Upadhyay S., Li G., Liu H., Chen Y.Q., Sarkar F.H., and Kim H.-E.C. Bcl-2 suppresses expression of p21WAF1/CIP1 in breast epithelial cells. Cancer Res. 55 (1995) 4520-4524
145. Vaux D.L., Cory S., and Adams J.M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (London) 335 (1988) 440-442
146. Vaux D.L., Weissman I.L., and Kim S.K. Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science 258 (1992) 1955-1957
147. Veis D.J., Sentman C.L., Bach E.A., and Korsmeyer S.J. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T lymphocytes. J. Immunol. 151 (1993) 2546-2554
148. Veis D.J., Sorenson C.M., Shutter J.R., and Korsmeyer S.J. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75 (1993) 229-240
149. Vogelstein B., and Kinzler K.W. P53 function and dysfunction. Cell 70 (1992) 523-526
150. Wang H.-G., Miyashita T., Takayama S., Sato T., Torigoe T., Krajewski S., Tanaka S., Hovey III L., Troppmair J., Rapp U.R., and Reed J.C. Apoptosis regulation by interaction of bcl-2 protein and Raf-1 kinase. Oncogene 9 (1994) 2751-2756
151. Wang H.-G., Millan J.A., Cox A.D., Der C.J., Rapp U.R., Beck T., Zha H., and Reed J.C. R-ras promotes apoptosis caused by growth factor deprivation via a Bcl-2 suppressible mechanism. J. Cell Biol. 129 (1995) 1103-1114
152. Wang T.T.Y., and Phang J.M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55 (1995) 2487-2489
153. Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., and Korsmeyer S.J. Bad: A heterodimeric partner for Bcl-XL and Bcl-2, displaces bax and promotes cell death. Cell 80 (1995) 285-291
154. Yang T., Kozopas K.M., and Craig R.W. The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J. Cell Biol. 128 (1995) 1173-1184
155. Yin X.M., Oltvai Z.N., and Korsmeyer S.J. BH1 and BH2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature (London) 369 (1994) 321-333
156. Yuan J., Shaham S., Ledoux S., Ellis H.M., and Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75 (1993) 641-652
157. Yunis J.J., Mayer M.G., Arensen M.A., Aeppli D.P., Oken M.M., and Frizzera G. Bcl-2 and other genomic alterations in the prognosis of large-cell lymphomas. New Engl. J. Med. 320 (1989) 1047-1054
158. Zha H., Aime-Sempe C., Sato T., and Reed J.C. Pro-apoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. Biol. Chem. 271 (1996) 7440-7444
159. Zha H., Fisk H.A., Yaffe M.P., and Reed J.C. Structure-function comparisons of proapoptotic protein Bax in yeast and mammalian cells. Mol. Cell Biol. 16 (1996) 6494-6508
160. Zhan Q., Fan S., Bae I., Guillouf C., Liebermann D.A., O'Connor P.M., and Fornace Jr. A.J. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9 (1994) 3743-3751
161. Zhang Z., Vuori K., Reed J.C., and Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 6161-6165